SYRS Syros Pharmaceuticals Inc.: Earnings per one share for the last 12 months

Syros (SYRS) - corporate logo

Syros Pharmaceuticals (SYRS) is integrating bioethics and environmental control principles into the development of genetic medicines. However, capital shortages and the risks of clinical trial failures pose serious threats. The year-over-year EPS growth dynamics over a rolling period visualize this balance, where the current parameter equals 76.70. Business stability is maintained by outsourcing research to external CROs under strict management supervision.

Syros Pharmaceuticals - SYRS Net earnings per share (EPS TTM) (period 02/11/2024 - 02/20/2024)

SYRS (syros.com): analytical breakdowns and indicator data

- company stock capitalization data:
Fundamental company valuation:SYRS - Syros Pharmaceuticals, Inc.
Product sample of Syros Pharmaceuticals

Syros Pharmaceuticals (SYRS) operates in the high-risk zone of clinical trials, where confidence in technology drives capitalization. This relative EPS YoY TTM growth metric smooths out quarterly volatility by calculating the percentage change in earnings per share over a rolling year. Analyzing the line's trajectory allows for the identification of a systemic decline in profitability before a market crash occurs. For the cautious biotech sector, such price action serves as an indicator of operational resilience. Monitoring this metric helps distinguish temporary development challenges from fundamental business degradation.

Competitor analysis for Syros Pharmaceuticals

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RGNX|Net earnings per share for the last 12 months SLDB|Net earnings per share (EPS TTM) Ocugen Inc|Earnings per share for the last twelve months PacBio Corp (PACB)|Net earnings per share for the last four quarters Benitec Corp|Net earnings per share (EPS TTM) DSGN (Design Therapeutics, Inc.)|Net earnings per share (EPS TTM) rocketpharma.com RCKT|4DMT - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Earnings per share for the last twelve months|Earnings per share for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Net earnings per share (EPS TTM)|proqr.com (PRQR) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CDXS (Codexis Bio)|SGMO - Net earnings per one share for the last twelve months|Nautilus Biotechnology, Inc. - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Metagenomi, Inc|Precision BioSciences - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Earnings per share for the last twelve months|Exicure Inc. - Earnings per share for the trailing year|IMNN (imunon.com) - Net earnings per share (EPS TTM)|Phio Pharmaceuticals - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Mustang Bio Corp (MBIO)|Net earnings per share (EPS TTM) TransCode (RNAZ)|Net earnings per share (EPS TTM) BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Earnings per one share for the last 12 months|BLUE - Earnings per share for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Net earnings per share for the last 12 months|OMGA (Omega) - Net earnings per share for the last 12 months|singulargenomics.com (OMIC) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months RGLS|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX